R923(A) - Open for Recruitment
Gender: Male and Female
Smoking habit: Non / Ex-smoker only
18 - 99
BMI : 18.00 - 33.00
Food restrictions : Fast
Lonafarnib is being developed to treat chronic hepatitis D virus (HDV) infection.
Dose: 50 mg lonafarnib
Ritonavir is FDA approved to treat human immunodeficiency virus (HIV). It is being used in this study as a booster to increase the concentration of lonafarnib in your body. A booster is a drug that keeps your body from breaking down a drug before it works.
Dose: Lonafarnib 50-mg capsule, Ritonavir 100-mg tablet, Loperamide 2-mg caplet
Male volunteers must surgically sterile. Female volunteers must be surgically sterile or postmenopausal. Please call us a 701-356-4000 for more details.
This is preliminary information and changes could occur without notice